The Board of Directors of Santen Pharmaceutical Co., Ltd. has authorized a buyback plan on May 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,603 JPY | -0.09% |
|
+2.04% | +14.09% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.09% | 3.63B | |
+51.63% | 798B | |
+41.51% | 633B | |
-5.10% | 356B | |
+19.90% | 328B | |
+9.95% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+6.99% | 166B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Santen Pharmaceutical Co., Ltd. authorizes a Buyback Plan.